AVEO Pharmaceuticals (AVEO) Tops Q1 EPS by 4c

AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
• Activist investors push Seer, Inc. to disclose go-private timeline